700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Review Article Open Access
Now safety concern of in vivo nano-carriers toxicity is apparently hindering the extensive applications of nanotechnology in medical sciences. Many studies on the effects of nanomaterials in vitro and in vivo have been published, and revealed that nanomaterials including carbon nanotubes, fullerenes, quantum dots (for example CdS) and oxide nanoparticles (NPs) (for example ZnO, CuO and TiO2) exhibited various toxic effects on biological system. More importantly, they can cause lung inflammation, liver injury, kidney failure, or even fatality . Compared with non-biodegradable nanomaterials, the same nano sized drug carriers prepared by biodegradable ones, such as albumin (Abraxane®) and phosphatides (Doxil®) used in human being approved by FDA, are fairly safe [2-4].
To read the full article Peer-reviewed Article PDF
Author(s): Mingyuan Li, Zhiping Li, Zhenbo Yang and Xingguo Mei
Nanotoxicity, Physical Damage, Nanomaterials, Biodegradable NPs, harmaceutics,Molecular Drug Design,Alternative Medicines